Jeffrey Craig Adams

US Patent:

6878714, Apr 12, 2005

Filed:

Jul 17, 2002

Appl. No.:

10/197974

Inventors:

Benny Askew - Newbury Park CA, US
Jeffrey Adams - Thousand Oaks CA, US
Shon Booker - Thousand Oaks CA, US
Guoqing Chen - Thousand Oaks CA, US
Lucian V. DiPietro - Gloucester MA, US
Daniel Elbaum - Newton MA, US
Julie Germain - Medford MA, US
Stephanie D. Geuns-Meyer - Medford MA, US
Gregory J. Habgood - Merrimac MA, US
Michael Handley - Greenbrae CA, US
Qi Huang - Moorpark CA, US
Aiwen Li - Westlake Village CA, US
Nobuko Nishimura - West Hills CA, US
Rana Nomak - Istanbul, TR
Vinod F. Patel - Acton MA, US
Babak Riahi - Woodland Hills CA, US
Joseph L. Kim - Wayland MA, US
Ning Xi - Thousand Oaks CA, US
Kevin Yang - San Gabriel CA, US
Chester Chenguang Yuan - Newbury Park CA, US

Assignee:

Amgen Inc. - Thousand Oaks CA

International Classification:

A61K031/4427
C07D401/12

US Classification:

514256, 514300, 514314, 514333, 514336, 514337, 544333, 546113, 546175, 546256, 546262, 5462717, 5462821, 5462827

Abstract:

Selected amines are effective for prophylaxis and treatment of diseases, such as angiogenesis mediated diseases. The invention encompasses novel compounds, analogs, prodrugs and pharmaceutically acceptable salts thereof, pharmaceutical compositions and methods for prophylaxis and treatment of diseases and other maladies or conditions involving, cancer and the like. The subject invention also relates to processes for making such compounds as well as to intermediates useful in such processes.

US Patent:

6995162, Feb 7, 2006

Filed:

Jan 10, 2002

Appl. No.:

10/046681

Inventors:

Guoqing Chen - Thousand Oaks CA, US
Jeffrey Adams - Thousand Oaks CA, US
Jean Bemis - Arlington MA, US
Shon Booker - Newbury Park CA, US
Guolin Cai - Thousand Oaks CA, US
Lucian Di Pietro - Gloucester MA, US
Celia Dominguez - Thousand Oaks CA, US
Daniel Elbaum - Newton MA, US
Julie Germain - Somerville MA, US
Stephanie Geuns-Meyer - Medford MA, US
Michael Handley - Ventura CA, US
Qi Huang - Moorpark CA, US
Joseph L. Kim - Wayland MA, US
Alexander Kiselyov - Jersey City NJ, US
Xiaohu Ouyang - Flushing NY, US
Vinod F. Patel - Acton MA, US
Leon M. Smith - Somerset NJ, US
Markian Stec - Filmore CA, US
Andrew Tasker - Simi Valley CA, US
Ning Xi - Thousand Oaks CA, US
Shimin Xu - Newbury Park CA, US
Chester Chenguang Yuan - Newbury Park CA, US
Michael Croghan - Ventura CA, US

Assignee:

Amgen Inc. - Thousand Oaks CA

International Classification:

A61K 31/435
C07D 213/82

US Classification:

514256, 514300, 514314, 514333, 514336, 514337, 544333, 546113, 546175, 546256, 546262, 5462717, 5462821, 5462827

Abstract:

Selected heterocyclic compounds are effective for prophylaxis and treatment of diseases, such as angiogenesis mediated diseases. The invention encompasses novel compounds, analogs, prodrugs and pharmaceutically acceptable derivatives thereof, pharmaceutical compositions and methods for prophylaxis and treatment of diseases and other maladies or conditions involving, cancer and the like. The subject invention also relates to processes for making such compounds as well as to intermediates useful in such processes.

US Patent:

7105682, Sep 12, 2006

Filed:

Jan 10, 2002

Appl. No.:

10/046622

Inventors:

Guoqing Chen - Thousand Oaks CA, US
Jeffrey Adams - Thousand Oaks CA, US
Jean Bemis - Arlington MA, US
Lucian Di Pietro - Gloucester MA, US
Celia Dominguez - Thousand Oaks CA, US
Daniel Elbaum - Newton MA, US
Julie Germain - Somerville MA, US
Qi Huang - Moorpark CA, US
Joseph L. Kim - Wayland MA, US
Xiaohu Ouyang - Flushing NY, US
Vinod F. Patel - Acton MA, US
Leon M. Smith - Sommerset NJ, US
Andrew Tasker - Simi Valley CA, US
Ning Xi - Thousand Oaks CA, US
Shimin Xu - Newbury Park CA, US
Chester Chenguang Yuan - Newbury Park CA, US
Michael Croghan - Ventura CA, US

Assignee:

Amgen Inc. - Thousand Oaks CA

International Classification:

C07D 401/02
A61K 31/44

US Classification:

5462771, 546194, 546199, 5462737, 5462757, 544253, 514255, 514318, 514338, 514339

Abstract:

Selected amines are effective for prophylaxis and treatment of diseases, such as angiogenesis mediated diseases. The invention encompasses novel compounds, analogs, prodrugs and pharmaceutically acceptable salts thereof, pharmaceutical compositions and methods for prophylaxis and treatment of diseases and other maladies or conditions involving, cancer and the like. The subject invention also relates to processes for making such compounds as well as to intermediates useful in such processes.

US Patent:

7248678, Jul 24, 2007

Filed:

Feb 7, 2003

Appl. No.:

10/360897

Inventors:

Jeffrey Nicholas Adams - Charlotte NC, US
Sedelia Boudreaux - Charlotte NC, US
Christopher D. Cordom - Herndon VA, US
June Snyder Fusco - Lexington SC, US
Robert Eric Grundmann - Charlotte NC, US
Rodell Scott Sweet - Charlotte NC, US

Assignee:

Avaya Technology Corp. - Basking Ridge NJ

International Classification:

H04M 1/64
H04M 11/00
H04M 15/00

US Classification:

379126, 379 8801, 379 8802, 379 8827, 37912703

Abstract:

Techniques and systems for routing and information collection for telephone calls are described. Upon initiation of a revenue generating call, a data management module creates a call interaction record, including a unique call identifier and information generated by an exchange originating the call. Call accounting information such as user identification and billing account information are collected from the user by presenting audible queries from the user and receiving voice responses. The voice responses are matched to stored information, which is stored in the call interaction record. If a voice response does not unambiguously identify the requested information, further queries may be presented to elicit more refined responses or request responses for recording and later playback. Routing information is then collected, again through audible queries and voice responses, and stored. Upon completion of the call, the call interaction record is closed and stored for later retrieval and analysis.

US Patent:

7320992, Jan 22, 2008

Filed:

Aug 24, 2004

Appl. No.:

10/926238

Inventors:

Christopher Tegley - Thousand Oaks CA, US
Jeffrey A. Adams - Thousand Oaks CA, US
Michael Croghan - Thousand Oaks CA, US
Daniel Elbaum - Newton MA, US
Julie Germain - Medford MA, US
Gregory J. Habgood - Merrimac MA, US
Scott Harried - Woodland Hills CA, US
Aiwen Li - Westlake Village CA, US
Nobuko Nishimura - West Hills CA, US
Rana Nomak - Istanbul, TR
Andrew Tasker - Simi Valley CA, US
Kevin Yang - San Gabriel CA, US

Assignee:

Amgen Inc. - Thousand Oaks CA

International Classification:

A61K 31/4439
C07D 401/12

US Classification:

514339, 5462771, 546152, 546139, 546113, 548472, 544111, 514416, 514314, 514307, 514300, 5142315

Abstract:

Selected compounds are effective for prophylaxis and treatment of diseases, such as angiogenesis mediated diseases. The invention encompasses novel compounds, analogs, prodrugs and pharmaceutically acceptable salts thereof, pharmaceutical compositions and methods for prophylaxis and treatment of diseases and other maladies or conditions involving, cancer and the like. The subject invention also relates to processes for making such compounds as well as to intermediates useful in such processes.

US Patent:

7514564, Apr 7, 2009

Filed:

May 2, 2006

Appl. No.:

11/417329

Inventors:

Guoqing Chen - Thousand Oaks CA, US
Jeffrey Adams - Thousand Oaks CA, US
Jean Bemis - Arlington MA, US
Lucian Di Pietro - Gloucester MA, US
Celia Dominguez - Thousand Oaks CA, US
Daniel Elbaum - Newton MA, US
Julie Germain - Somerville MA, US
Qi Huang - Moorpark CA, US
Joseph L. Kim - Wayland MA, US
Xiaohu Ouyang - Flushing NY, US
Vinod F. Patel - Acton MA, US
Leon M. Smith - Somerset NJ, US
Andrew Tasker - Simi Valley CA, US
Ning Xi - Thousand Oaks CA, US
Shimin Xu - Newbury Park CA, US
Chester Chenguang Yuan - Newbury Park CA, US
Michael Croghan - Ventura CA, US

Assignee:

Amgen Inc. - Thousand Oaks CA

International Classification:

C07D 211/94
C07D 211/98
A61K 31/44

US Classification:

546304, 546290, 546296, 546297, 546300, 546301, 546302, 546303, 546312, 514345, 514349, 514352

Abstract:

Selected amines are effective for prophylaxis and treatment of diseases, such as angiogenesis mediated diseases. The invention encompasses novel compounds, analogs, prodrugs and pharmaceutically acceptable salts thereof, pharmaceutical compositions and methods for prophylaxis and treatment of diseases and other maladies or conditions involving, cancer and the like. The subject invention also relates to processes for making such compounds as well as to intermediates useful in such processes.

US Patent:

8642624, Feb 4, 2014

Filed:

Nov 15, 2011

Appl. No.:

13/297213

Inventors:

Guoqing Chen - Thousand Oaks CA, US
Jeffrey A. Adams - Chagrin Falls OH, US
Jean E. Bemis - Arlington MA, US
Shon Booker - Thousand Oaks CA, US
Guolin Cai - Thousand Oaks CA, US
Lucian V. DiPietro - Gloucester MA, US
Celia Dominguez - Los Angeles CA, US
Daniel Elbaum - Newton MA, US
Julie Germain - Somerville MA, US
Stephanie Geuns-Meyer - Medford MA, US
Michael K. Handley - Greenbrae CA, US
Qi Huang - Moorpark CA, US
Joseph L. Kim - Wayland MA, US
Alexander S. Kiselyov - Jersey City NJ, US
Xiaohu Ouyang - Brooklyn NY, US
Vinod F. Patel - Acton MA, US
Leon M. Smith - Somerset NJ, US
Markian M. Stec - Moorpark CA, US
Andrew Tasker - Simi Valley CA, US
Ning Xi - Thousand Oaks CA, US
Shimin Xu - San Diego CA, US
Chester Chenguang Yuan - Newbury Park CA, US
Michael D. Croghan - Thousand Oaks CA, US

Assignee:

Amgen Inc. - Thousand Oaks CA

International Classification:

A01N 43/40
A61K 31/44
A01N 43/38
A61K 31/40
A61K 31/405

US Classification:

514333, 514352, 514355, 514415, 514277, 514414

Abstract:

Selected heterocyclic compounds are effective for prophylaxis and treatment of diseases, such as angiogenesis mediated diseases. The invention encompasses novel compounds, analogs, prodrugs and pharmaceutically acceptable derivatives thereof, pharmaceutical compositions and methods for prophylaxis and treatment of diseases and other maladies or conditions involving, cancer and the like.

US Patent:

20050261313, Nov 24, 2005

Filed:

Dec 15, 2004

Appl. No.:

11/014184

Inventors:

Benny Askew - Newbury Park CA, US
Jeffrey Adams - Thousand Oaks CA, US
Shon Booker - Newbury Park CA, US
Guoqing Chen - Thousand Oaks CA, US
Lucian DiPietro - Gloucester MA, US
Daniel Elbaum - Newton MA, US
Julie Germain - Somerville MA, US
Stephanie Geuns-Meyer - Medford MA, US
Gregory Habgood - Merrimac MA, US
Michael Handley - Ventura CA, US
Qi Huang - Moorpark CA, US
Aiwen Li - Westlake Village CA, US
Nobuko Nishimura - West Hills CA, US
Rana Nomak - Westlake Village CA, US
Vinod Patel - Acton MA, US
Babak Riahi - Woodland Hills CA, US
Joseph Kim - Wayland MA, US
Ning Xi - Thousand Oaks CA, US
Kevin Yang - San Gabriel CA, US
Chester Yuan - Newbury Park CA, US

International Classification:

C07D491/02
C07D471/02
C07D043/02
C07D041/02
A61K031/506
A61K031/4709
A61K031/444
A61K031/4439

US Classification:

514256000, 514332000, 514300000, 514338000, 514314000, 544333000, 546113000, 546176000, 546255000, 546271700

Abstract:

Selected amines are effective for prophylaxis and treatment of diseases, such as angiogenesis mediated diseases. The invention encompasses novel compounds, analogs, prodrugs and pharmaceutically acceptable salts thereof, pharmaceutical compositions and methods for prophylaxis and treatment of diseases and other maladies or conditions involving, cancer and the like. The subject invention also relates to processes for making such compounds as well as to intermediates useful in such processes.

Address:

2052 W Ave K12, Lancaster, CA 93536

Phone:

6617183831

VIN:

2FMGK5CC5BBA00312

Make:

FORD

Model:

FLEX

Year:

2011

Address:

3317 Carlisle Ct, Fort Mill, SC 29715

VIN:

2D4GP44L47R329521

Make:

DODGE

Model:

GRAND CARAVAN

Year:

2007